Skip to main content
Normal View

Wednesday, 15 May 2013

Written Answers Nos. 257-265

Accident and Emergency Services Provision

Questions (257)

Patrick O'Donovan

Question:

257. Deputy Patrick O'Donovan asked the Minister for Health in relation to Wexford General Hospital, when it is envisaged that the new accident and emergency will open; if funding is in place to equip same; if it will require extra staff over and above staffing level in current accident and emergency; if existing staff are required, where they will be recruited or will they be appointed from existing staffing; and if he will make a statement on the matter. [23173/13]

View answer

Written answers

As this is a service matter, it has been referred to the HSE for direct reply.

Question No. 258 answered with Question No. 253.

Hospital Services

Questions (259)

Billy Timmins

Question:

259. Deputy Billy Timmins asked the Minister for Health if he will list the nineteen public obstetric units here [23240/13]

View answer

Written answers

Detailed in a table is the list of public obstetric units requested by the Deputy.

Dublin /Mid Leinster Region

1. Coombe Women's and Infants University Hospital

2. Midlands Regional Hospital Mullingar

3. Midland Regional Hospital Portlaoise

4. National Maternity Hospital Holles Street

Dublin North East / Region

5. Cavan General Hospital

6. Our of Lourdes Hospital Drogheda

7. Rotunda Hospital

Mid West Hospitals Group

8. Mid Western Regional Maternity Hospital

South Region

9. South Tipperary General Hospital

10. St. Lukes Hospital Kilkenny

11. Waterford Regional Hospital

12. Wexford General Hospital

13. Cork University Maternity Hospital

14. Kerry General Hospital

West Region

15. Letterkenny General Hospital

16. Mayo General Hospital

17. Sligo General Hospital

18. Galway University Hospitals

19. Portiuncula Hospital General and Maternity Ballinasloe

Mental Health Services Provision

Questions (260)

Billy Timmins

Question:

260. Deputy Billy Timmins asked the Minister for Health the centres which are registered by the Mental Health Commission under the Mental Health Act 2001 [23241/13]

View answer

Written answers

Under the Mental Health Act 2001, a 'centre' is defined as a hospital or other in-patient facility for the care and treatment of persons suffering from metal illness or mental disorder. All facilities that operate as a 'centre' as defined in the Act, must be registered by the Mental Health Commission. Section 63 of the Mental Health Act 2001 states that 'a person shall not carry on a centre unless the centre is registered and the person is the registered proprietor thereof and a centre which so registered shall be known and is referred to in this Act as an approved centre'. Once a centre is registered by the Commission, it is entered in the register of approved centres and each centre's registration lasts for three years from the date of registration.

Full details on the list of registered of approved centres, including access to reports carried out by the Inspector of Mental Health Services are available on the website of the Mental Health Commission, www.mhcirl.ie.

Abortion Legislation

Questions (261)

Billy Timmins

Question:

261. Deputy Billy Timmins asked the Minister for Health further to Parliamentary Question No. 240 of 8 May 2013, if there were draft terms of reference for the expert group; if so, what there were; the brief he gave the chairman of the external group; the nominations received from the Irish College of General Practitioners, the Institute of Obstetricians and Gynaecologists, the College of Psychiatrists of Ireland, an Bord Altranais, and the Medical Council; who, if any, of these were selected; the personnel other than those nominated above that were on the group; and the persons who nominated them; and if the meetings held in his Department may the accessed to view or copy [23242/13]

View answer

Written answers

As the Deputy will be aware from his previous question on this area, the terms of reference for the Expert Group were initially drawn up by the relevant officials in my Department, after which they were submitted for discussion by Government, and approved on the 29th November 2011. As the question relates to confidential matters for Cabinet, I will not be commenting any further.

Again, the Deputy will be aware from my previous reply that the membership of the Expert Group was chosen and appointed by the Minister and approved by Government. The Group consisted of members selected on the basis of their medical, legal, and policy expertise, and no further personnel were members of the Group.

The nominations from the Irish College of General Practitioners, the Institute of Obstetricians and Gynaecologists, the College of Psychiatrists of Ireland, an Bord Altranais, and the Medical Council were each provided to me in confidence, and those appointed are on the public record.

Under the terms of the Freedom of Information Acts 1997 and 2003, all records held by the Department of Health are accessible to the public. Finally, I have set out the letter of appointment of the Chair of the Expert Group with relevant briefing as requested.

13th January 2012

Hon. Justice Mr. Sean Ryan

High Court

Four Courts

Inns Quay

Dublin 7

Re: Expert Group on the A, B, and C-v-Ireland judgment of the

European Court of Human Rights

Dear Hon. Justice Mr. Sean Ryan,

I would like to thank you most sincerely for agreeing to chair the Expert Group on the A, B, and C-v-Ireland judgment of the European Court of Human Rights.

The terms of reference for the Group which have been approved by Government are:

- To examine the A, B and C v Ireland judgment of the European Court of Human Rights;

- To elucidate its implications for the provision of health care services to pregnant women in Ireland;

- To recommend a series of options on how to implement the judgment taking into account the constitutional, legal, medical, and ethical considerations involved in the formulation of public policy in this area and the over-riding need for speedy action.

You will find enclosed a document outlining the membership of the Group and a brief summary of the judgment.

I appreciate that the task at hand is a difficult and complex one, and that the timeframe of six months for finalising your work is challenging. However, the Government is committed to ensuring that the judgment is implemented expeditiously and the Expert Group will play a vital role in formulating recommendations on how to progress in this matter. In order to meet this deadline, the Expert Group will meet on a periodic basis (at least monthly) and may consult with interested parties and additional relevant experts and professionals.

The Expert Group will be provided with a secretariat and meetings will be held in the Department. My officials will be in touch with you with further details in due course. In the meantime, please do not hesitate to contact the senior official responsible for this Group, Ms. Geraldine Luddy, Principal Officer, at 01 635 4063 or geraldine_luddy@health.gov.ie should you have any queries.

Finally I would like to repeat my appreciation for your willingness to participate in the Group and I wish you well in your deliberations.

Yours sincerely,

__________________

Dr. James Reilly, T.D.

Minister for Health

Membership of the Expert Group on the A, B and C-v Ireland judgment of 16th of December 2010 of the European Court of Human Rights

No

Expertise

Organisation 

1

Chair

Hon. Justice Mr. Sean Ryan

3

Obstetrics

Dr Peter Boylan ,

Consultant Obstetrician/Gynaecologist

Dr Mary Holohan,

Consultant Obstetrician/Gynaecologist

4

Psychiatry

Dr Imelda Ryan  Psychiatrist

5

6

General Practice

Dr Ailis Ni Riain

Dr Mark Walsh

7

Ms Christine O’Rourke,

Office of the Attorney General

8

Ms Mary O Toole,

Senior Counsel

9

Ms Joanelle O’Cleirigh,

Solicitor

10

Law

Ms Denise Kirwin,

Solicitor

11

Mr. Bernard Carey,

Assistant Secretary,

Department of Health

12

Policy

Dr  Tony Holohan, 

Chief Medical Officer,

Department of Health

13

Professional Standards – Doctors

Dr. Deirdre Madden

nominated by Medical Council

14

Professional Standards – Midwives

Dr Maura Pidgeon

nominated by

An Bord Altranais 

(Nursing Board)

Background on A, B, and C -v- Ireland Case

A, B, and C- v- Ireland judgment

The European Court of Human Rights heard in December 2009 an application by three women that it is a breach of their rights under the Council of Europe Convention on Human Rights for the Irish State not to provide abortion in circumstances where a woman wishes to undergo an abortion (the A, B and C case).

The judgement of the Court confirms that Article 40.3.3 of the Constitution is in conformity with the European convention on Human Rights. The Court accepted that Article 40.3.3 of the Irish Constitution, as interpreted by the Supreme Court in the X case, provides that it is lawful to terminate a pregnancy in Ireland if it is established as a matter of probability that there is a real and substantial risk to the life, as distinct from the health, of the mother, which can only avoided by a termination of the pregnancy. This has not been altered by this judgment.

The Court held:

- In the case of the first and second applicants, Ms A and Ms B, the Court dismissed their applications, finding that there had been no violation of their rights under the Convention;

- In the case of the third applicant, Ms C, the Court found that Ireland had failed to respect the applicant’s private life contrary to Article 8 of the Convention, as there was no accessible and effective procedure to enable her to establish whether she qualified for a lawful termination of pregnancy in accordance with Irish law.

The Court ruled that "no criteria or procedures have been... laid down in Irish law... by which that risk is to be measured or determined, leading to uncertainty…" and held that further legal clarity was required.

Execution of the Judgment

Steps need to be taken to ensure no future similar violations of Article 8 occur. While the State is free, within certain limits, to choose the means of execution it is legally bound to attain the execution result required. This means that while the State can choose the means of implementation, it needs to achieve legal clarity as to when a woman may qualify for a lawful termination of pregnancy.

Disabled Drivers and Passengers Scheme

Questions (262)

Joan Collins

Question:

262. Deputy Joan Collins asked the Minister for Health if there are any supports available to a person (details supplied) in Dublin 12 to adapt a car. [23245/13]

View answer

Written answers

The Disabled Drivers and Disabled Passengers Scheme provides a range of tax reliefs linked to the purchase and use of vehicles by disabled drivers and disabled passengers in Ireland. The rules of the scheme are set out in the Disabled Drivers and Disabled Passengers (Tax Concessions) Regulations 1994. The scheme is administered by the Revenue Commissioners and information is available on www.citizensinformation.ie and www.revenue.ie.

A Project Group has been established to seek an alternative method to provide for the priority transport needs of people with a disability in a manner that does not run counter to the Equal Status Acts. The Group is reviewing the mobility allowance and the motorised transport grant. It will report to Government by the end of this month. The results of the review will be presented to the Government before any final decisions are made on future arrangements for mobility supports for people with a disability. I am not in a position to pre-empt the outcome of the review or the decision of Government.

Medicinal Products Prices

Questions (263)

Patrick O'Donovan

Question:

263. Deputy Patrick O'Donovan asked the Minister for Health when approval for funding will be given for the drug Eculizumab; and if he will make a statement on the matter. [23248/13]

View answer

Written answers

The drug mentioned by the Deputy is extremely expensive, costing over €350,000 per patient per year. Treatment is lifelong. In 2010, in the absence of sufficient information to make a decision regarding long term funding, the HSE entered into an agreement with the manufacturer and St James’ Hospital, Dublin, whereby it provided a fund of almost €10m (inclusive of VAT) for the years 2010 to 2012. This level of funding was seen as sufficient to treat 10 patients, the expected number of patients to be identified for treatment over that time period. The agreement provided that continued funding of Eculizumab would be contingent on the results of a HSE commissioned evaluation of the clinical and economic information associated with the use of this drug. In this context, it was understood that the manufacturer was working with clinical experts internationally to develop the evidence to support continued funding of this very expensive drug.

The HSE has honoured the terms of the 2010 agreement. The agreement has now lapsed and a formal re-assessment process has been triggered as was agreed in 2010. Pending consideration of the outcome of the assessment, the HSE is continuing to fund the treatment of the original 10 patients identified by St James’s Hospital. The HSE has released funding of €848,000 (plus 23% VAT) to fund treatment for these patients in the first four months of 2013.

The HSE is progressing with the formal re-assessment agreed in 2010 so as to ensure that funding decisions are made in the full knowledge of all the benefits and costs of this drug. The HSE understands that the manufacturer is working on a dossier setting out additional evidence in support of this drug and the HSE awaits its submission. The National Centre for Pharmacoeconomics has been requested to examine that dossier on behalf of the HSE once it is submitted. Future funding decisions will be made when the assessment report is available.

Medicinal Products Availability

Questions (264)

Billy Kelleher

Question:

264. Deputy Billy Kelleher asked the Minister for Health the plans that are in place to deal with the shortage of Augmentin which is currently being experienced by hospitals throughout the country; in view of this, and other medicine shortages in recent months, the actions that have been taken to ensure early notification of emerging medicine shortages to hospitals and patients to deal with such shortages and to ensure that there are alternative suppliers available to supply Irish patients; and if he will make a statement on the matter. [23249/13]

View answer

Written answers

Over the last number of months hospitals have been experiencing a shortage of Augmentin intravenous products (Augmentin IV). This shortage is due to manufacturing capacity issues which the manufacturer, GlaxoSmithKline (GSK) is experiencing at its manufacturing site in the United Kingdom.

A number of measures are in place to deal with this shortage and minimise its impact on the delivery of essential health services. GSK, is closely monitoring supply and ensuring that product stocks are available for those considered most vulnerable and consequently the supply of Augmentin IV to hospitals has been and will continue to be rationed, with paediatric hospitals being prioritised.

For other hospitals there are two generic IV amoxicillin / clavulanic acid products currently authorised in Ireland. The Irish Medicines Board (IMB) has put in place measures to facilitate the continued supply of these alternative products until such time as normal supplies of Augmentin IV are resumed.

Clinical leadership within the HSE made clinical microbiologists, infectious diseases physicians and antimicrobial pharmacists aware of the potential issues in March 2013 and requested that individual hospitals consider preparation of contingency plans to guide clinicians on potential alternatives to Augmentin IV in the event that alternatives were required.

My Department works closely with the IMB and the HSE to identify and address medicines shortages so as to minimise their impact on patients. Shortages are a global issue and can arise for a variety of reasons, including, as in the case in Augmentin IV, production issues at a manufacturing facility. In the event of a particular shortage, priority is given to restoring supply as quickly as possible and to identifying and securing continued supply of alternative products. Manufacturers, wholesalers and pharmacies all have responsibility to work together to identify shortages and implement alternative arrangements to meet the needs of patients.

Hospital Waiting Lists

Questions (265)

Sean Conlan

Question:

265. Deputy Seán Conlan asked the Minister for Health the reason a person (details supplied) has been waiting for more than three years for a hospital appointment; and if he will make a statement on the matter. [23250/13]

View answer

Written answers

Improving access to outpatient services is a key priority for the Government. Building on work already undertaken by the HSE, the National Treatment Purchase Fund has now taken over the reporting of outpatient waiting time data. For the first time data is available on www.ntpf.ie. The collation and analysis of outpatient waiting time data in a standardised format will reveal the distribution of long waiters across all hospitals. In the first instance, this will allow resources to be targeted towards those patients who are waiting longest and ensure that they are seen and assessed. For 2013, a maximum waiting time target has now been set of 12 months for a first time outpatient appointment.

In parallel with reducing the numbers of longest waiters, the SDU will also work with the HSE Clinical Programmes to reform the structure, organisation and delivery of outpatient services to ensure that the right patient is seen and assessed by the right health professional at the right time.

Should the patient's general practitioner consider that the patient's condition warrants an earlier appointment, he/she would be in the best position to take the matter up with the consultant and hospital involved.

In relation to the specific query raised by the Deputy, as this is a service matter it has been referred to the HSE for direct reply.

Top
Share